InvestorsHub Logo
Followers 75
Posts 4645
Boards Moderated 0
Alias Born 09/06/2003

Re: biotech_researcher post# 7033

Tuesday, 04/16/2024 10:36:54 AM

Tuesday, April 16, 2024 10:36:54 AM

Post# of 7226

Therapeutics might be the only way out of this mess.



No:

A) ~half the therapeutic market is migraine, on which Allergan has patents.
B) it’s going to take significant time to develop the Daxxy specific protocol on Spastic Limb, which is the majority of the remainder
C) by having to lower their price in aesthetics, and, unlike Allergan, using the same price in therapeutics plus lasting longer per treatment, the total market will be much lower.

There isn’t that much near term (next few years) money for Revance in therapeutics.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News